Scott Fidel
Stock Analyst at Stephens & Co.
(1.79)
# 3,115
Out of 4,870 analysts
184
Total ratings
40%
Success rate
4.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Reiterates: Overweight | $21 | $12.94 | +62.29% | 5 | May 20, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $112.99 | +25.67% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $28.19 | +34.80% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $97.84 | +3.23% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $173.52 | +28.52% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $13.97 | +21.69% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $53.40 | +36.70% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $300.68 | +124.49% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $12.75 | +143.14% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $316.97 | +29.35% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $152.17 | +9.75% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $20.32 | +3.35% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $234.66 | +6.54% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $372.42 | +65.14% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $120.22 | -12.66% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $291.14 | +9.91% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $169.12 | -27.86% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $20.85 | +341.25% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $378.72 | -26.07% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $3.39 | +2,702.36% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $4.87 | -69.17% | 3 | Nov 11, 2022 |
Ardent Health
May 20, 2025
Reiterates: Overweight
Price Target: $21
Current: $12.94
Upside: +62.29%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $112.99
Upside: +25.67%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $28.19
Upside: +34.80%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $97.84
Upside: +3.23%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $173.52
Upside: +28.52%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $13.97
Upside: +21.69%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $53.40
Upside: +36.70%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $300.68
Upside: +124.49%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $12.75
Upside: +143.14%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $316.97
Upside: +29.35%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $152.17
Upside: +9.75%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $20.32
Upside: +3.35%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $234.66
Upside: +6.54%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $372.42
Upside: +65.14%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $120.22
Upside: -12.66%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $291.14
Upside: +9.91%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $169.12
Upside: -27.86%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $20.85
Upside: +341.25%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $378.72
Upside: -26.07%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $3.39
Upside: +2,702.36%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $4.87
Upside: -69.17%